ARDELYX, INC. Increase (Decrease) in Derivative Liabilities
ARDELYX, INC. (ARDX) reported Increase (Decrease) in Derivative Liabilities of $70.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2023-05-03
- ARDELYX, INC. increase (decrease) in derivative liabilities for the quarter ending 2023-03-31 was $70.00K, a 366.67% increase year-over-year.
- ARDELYX, INC. increase (decrease) in derivative liabilities for the quarter ending 2022-12-31 was $529.00K, a 2838.89% increase year-over-year.
- ARDELYX, INC. increase (decrease) in derivative liabilities for the quarter ending 2022-09-30 was $36.00K, a 111.76% increase year-over-year.
- ARDELYX, INC. increase (decrease) in derivative liabilities for the quarter ending 2022-06-30 was $3.00K.
- ARDELYX, INC. increase (decrease) in derivative liabilities for fiscal 2022 was $583.00K.
- ARDELYX, INC. increase (decrease) in derivative liabilities for fiscal 2021 was -$678.00K, a 266.58% decline from fiscal 2020.
- ARDELYX, INC. increase (decrease) in derivative liabilities for fiscal 2020 was $407.00K, a 6.65% decline from fiscal 2019.
- ARDELYX, INC. increase (decrease) in derivative liabilities for fiscal 2019 was $436.00K, a 292.79% increase from fiscal 2018.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2023-03-31 | $70.00K 10-Q · filed 2023-05-03 | $599.00K derived: sum of 2 quarters · filed 2023-05-03 | $635.00K derived: sum of 3 quarters · filed 2023-05-03 | $638.00K derived: sum of 4 quarters · filed 2023-05-03 |
| 2022-12-31 | $529.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $565.00K derived: sum of 2 quarters · filed 2023-03-02 | $568.00K derived: sum of 3 quarters · filed 2023-03-02 | $583.00K 10-K · filed 2023-03-02 |
| 2022-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $39.00K derived: sum of 2 quarters · filed 2022-11-03 | $54.00K 10-Q · filed 2022-11-03 | $72.00K derived: sum of 4 quarters · filed 2023-05-03 |
| 2022-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $18.00K 10-Q · filed 2022-08-04 | $36.00K derived: sum of 3 quarters · filed 2023-05-03 | $53.00K derived: sum of 4 quarters · filed 2023-05-03 |
| 2022-03-31 | $15.00K 10-Q · filed 2023-05-03 | $33.00K derived: sum of 2 quarters · filed 2023-05-03 | $50.00K derived: sum of 3 quarters · filed 2023-05-03 | -$699.00K derived: sum of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $35.00K derived: sum of 2 quarters · filed 2023-03-02 | -$714.00K derived: sum of 3 quarters · filed 2023-03-02 | -$678.00K 10-K · filed 2023-03-02 |
| 2021-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$732.00K derived: sum of 2 quarters · filed 2022-11-03 | -$696.00K 10-Q · filed 2022-11-03 | -$579.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | -$749.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$713.00K 10-Q · filed 2022-08-04 | -$596.00K derived: sum of 3 quarters · filed 2023-03-02 | -$458.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $36.00K 10-Q · filed 2022-05-05 | $153.00K derived: sum of 2 quarters · filed 2023-03-02 | $291.00K derived: sum of 3 quarters · filed 2023-03-02 | $361.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $255.00K derived: sum of 2 quarters · filed 2023-03-02 | $325.00K derived: sum of 3 quarters · filed 2023-03-02 | $407.00K 10-K · filed 2023-03-02 |
| 2020-09-30 | $138.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $208.00K derived: sum of 2 quarters · filed 2021-11-12 | $290.00K 10-Q · filed 2021-11-12 | $480.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $152.00K 10-Q · filed 2021-08-13 | $342.00K derived: sum of 3 quarters · filed 2022-02-28 | $527.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $82.00K 10-Q · filed 2021-05-06 | $272.00K derived: sum of 2 quarters · filed 2022-02-28 | $457.00K derived: sum of 3 quarters · filed 2022-02-28 | $481.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $375.00K derived: sum of 2 quarters · filed 2022-02-28 | $399.00K derived: sum of 3 quarters · filed 2022-02-28 | $436.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $185.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $209.00K derived: sum of 2 quarters · filed 2020-11-05 | $246.00K 10-Q · filed 2020-11-05 | $301.00K derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $61.00K 10-Q · filed 2020-08-06 | $116.00K derived: sum of 3 quarters · filed 2021-03-08 | |
| 2019-03-31 | $37.00K 10-Q · filed 2020-05-07 | $92.00K derived: sum of 2 quarters · filed 2021-03-08 | ||
| 2018-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $111.00K 10-K · filed 2021-03-08 | ||
| 2018-09-30 | $56.00K 10-Q · filed 2019-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |